CLIGAVYX
fulvestrant
- Strength
- 250 mg/5mL
- Form
- Injection
- Class
- Estrogen Receptor Antagonist
Avyxa Pharma, LLC
Not stocked by us — reference only
Listed by Dr.Reddy's Laboratories Inc
| Dosage form | Injection, Solution |
|---|---|
| Route | Intramuscular |
| Drug class | Estrogen Receptor Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 43598-262 |
| FDA application | ANDA209246 |
| RxNorm concept | 727762 |
| Package sizes listed | 1 |
| Marketed since | December 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
fulvestrant
Avyxa Pharma, LLC
Not stocked by us — reference only
Fulvestrant
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
Sandoz Inc
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
Meitheal Pharmaceuticals Inc
Not stocked by us — reference only
Northstar Rx, LLC,
Not stocked by us — reference only
Accord Healthcare Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.